Related Experiment Video
Updated: Oct 22, 2025
09:03
Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management
Published on: March 28, 2025
697
Optical Control of Adenosine-Mediated Pain Modulation
Katharina Hüll1,2, Víctor Fernández-Dueñas3,4, Matthias Schönberger2
1Department of Chemistry, New York University, 100 Washington Square East, New York City, New York 10003, United States.
Bioconjugate Chemistry
|August 27, 2021
Summary
Researchers developed light-activated adenosine derivatives to control pain relief. A novel compound, AzoAdenosine-3, reduced pain perception in a light-dependent manner, demonstrating a new method for studying adenosine receptors in pain management.
Area of Science:
- Pharmacology
- Neuroscience
- Biochemistry
Background:
- Adenosine receptors (ARs) are crucial in physiology and are potential targets for pain management.
- Optical control over G protein-coupled receptors offers novel therapeutic strategies.
Purpose of the Study:
- To develop photoswitchable adenosine derivatives for light-dependent activation of ARs.
- To investigate the role of ARs in pain relief using a novel light-controlled compound.
Main Methods:
- Synthesis of three photoswitchable adenosine derivatives.
- Evaluation of AzoAdenosine-3 in the formalin pain model in vivo.
- Assessment of antinociceptive effects under dark and light conditions.
Main Results:
- AzoAdenosine-3 demonstrated light-dependent antinociceptive effects.
- The compound was resistant to adenosine deaminase metabolism.
- Differential roles of AR subtypes (A1R, A3R, A2AR, A2BR) in mediating analgesia were suggested.
Conclusions:
- Photoswitchable adenosine derivatives provide optical control over ARs.
- This technology enables in vivo mapping of AR contributions to analgesia.
- Light-controlled AR modulation presents a promising avenue for pain relief research.
Related Concept Videos
01:25Analgesia and Pain Management
971
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
971
01:20Pain
875
Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
875
01:23Local Anesthetics: Mechanism of Action
2.7K
Local anesthetics (LAs) block sensory and motor impulses by inhibiting the sodium channels on the nerve cell membranes. This induces temporary loss of sensation, relieving pain in a specific body area.
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
2.7K
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
1.1K
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
1.1K
01:31Adrenergic Receptors: ɑ Subtype
2.3K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.3K
01:24Local Anesthetics: Differential Sensitivity of Nerve Fibers
1.1K
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
1.1K